Show results for
Refine by
Cancer Detection Suppliers Serving Senegal
61 companies found
based inSeoul, SOUTH KOREA
We make software that transforms medical data into deeper insight. Our AI technology takes medical intelligence to the next level: data-driven medicine. We aim to solve the most critical issues in cancer care today: reduce medical cost and prolong ...
Lunit INSIGHT CXR covers the vast majority of findings. Accurately detects 10 of the most common findings in a chest x-ray. Developed by using Lunit’s cutting-edge deep learning ...
based inKaohsiung City, TAIWAN
EPED Inc. is a leading company in the field of minimally invasive surgery. Upholding the values of “safety, precision, and efficiency”, we strive constantly to develop innovative medical and dental navigation solutions. From education, training ...
EPROB Robotic Arm + AI is the newest member of the EPED Inc. family. Having been in production for nearly decade, a heavy emphasis on precision, safety, and minimally invasive surgeries are just some of the features that have been developed in that ...
based inCortlandt Manor, NEW YORK (USA)
Polymedco is dedicated to enhancing early detection of life-threatening diseases as healthcare challenges intensify due to rising chronic disease rates, an aging population, and soaring medical costs. The company collaborates with healthcare ...
OC-Auto FIT is a fecal immunochemical test (FIT) designed to enhance colorectal cancer screening by offering a highly accurate and clinically supported method. The test is geared towards individuals aged 45 to 75, adhering to Tier 1 guidelines, ...
based inSeville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
We are developing Signal-X, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
PancreaDix is an innovative, non-invasive signature in blood for: Confirming a Pancreatic cancer diagnosis. Detecting pre-malignant lesions that will evolve to cancer. Performing a differential ...
based inMelville, NEW YORK (USA)
FONAR was incorporated in 1978, making it the first, oldest and most experienced MR manufacturer in the industry. FONAR introduced the world's first commercial MRI (a whole-body MRI scanner) in 1980, and went public in 1981. In 1982, FONAR ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
AlphaLiquid® Screening is a blood-based test for early detection of multiple cancers. With 10mL of blood, the test analyzes genetic and epigenetic features in cfDNA to screen for signals of ...
based inSan Juan Capistrano, CALIFORNIA (USA)
In late 1999, out of an urge to innovate and excel, John Bottjer, Nizar Mullani, and Thorsten Trotzenberg founded 3Gen as a cutting-edge product design and development company situated in beautiful Orange County, California. At the 2001 meeting of ...
based inGuro-gu, SOUTH KOREA
We provide diagnostic solutions throughout the cancer treatment cycle from early cancer diagnosis to prognostic and companion diagnostics as well as postoperative monitoring. Diagnose cancer as early as possible, when the disease is easiest to ...
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
INOVIQ’s NETs technology is a sample preparation platform with the potential to revolutionise the performance of liquid biopsy diagnostic assays. The market potential for liquid biopsy applications is estimated at billions of dollars ...
based inPeachtree Corners, GEORGIA (US) (USA)
Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests. Since Guided ...
Our patented technology, which features our flagship product the LuViva® Advanced Cervical Scan, uses biophotonics to detect both physical and chemical changes in tissues that are early signs of cancer. ...
based inIsfiya, ISRAEL
At Check-Cap our experienced and motivated team is committed to increasing screening adherence and helping to reduce the global incidence of colorectal cancer (CRC) through cancer prevention. Our patented technology C-Scan is the first and only ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per ...
based in, GERMANY
Since 1971, the family company CLA – Coburger Lehrmittelanstalt, company owner: Hans Sommer, has been offering CLA Nursing Dolls, Medical Training Phantoms, and the entire programme of Original SOMSO Models, thus providing a wide range for the ...
Produced in co-operation with Prof. Dr. J. Sökeland, Dortmund. Made of special plastic. An urological practice model that allows rectal examinations and palpation of the testicles to be learned under true-to-life ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic ...
based inOrlando, FLORIDA (USA)
Imaging Diagnostic Systems, Inc. (IDSI) is a medical device company headquartered in Florida, specializing in the research, development, and marketing of innovative cancer detection systems. Their flagship product, the CTLM system (Computed ...
Computed Tomography Laser Mammography (CTLM) is an innovative imaging method focused on visualizing blood distribution within the breast, helpful for identifying breast abnormalities. This technology offers potential advantages in ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), ...
based inParis Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority ...
based inNew York, NEW YORK (USA)
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management ...
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most ...